Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study.
about
A multicenter, observational study of lanreotide depot/autogel (LAN) in patients with acromegaly in the United States: 2-year experience from the SODA registry.Marked alteration of glycemic profile surrounding lanreotide administration in acromegaly: A case report.Screening for comorbid conditions in patients enrolled in the SODA registry: a 2-year observational analysis.
P2860
Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naïve patients with acromegaly: data from the PRIMARYS study.
description
2016 nî lūn-bûn
@nan
2016 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Glucose and lipid levels with ...... data from the PRIMARYS study.
@ast
Glucose and lipid levels with ...... data from the PRIMARYS study.
@en
type
label
Glucose and lipid levels with ...... data from the PRIMARYS study.
@ast
Glucose and lipid levels with ...... data from the PRIMARYS study.
@en
prefLabel
Glucose and lipid levels with ...... data from the PRIMARYS study.
@ast
Glucose and lipid levels with ...... data from the PRIMARYS study.
@en
P2093
P2860
P356
P1476
Glucose and lipid levels with ...... data from the PRIMARYS study.
@en
P2093
Aude Houchard
Caroline Sert
John S Bevan
PRIMARYS Study Group
Philippe J Caron
Stephan Petersenn
P2860
P304
P356
10.1111/CEN.13285
P577
2016-11-22T00:00:00Z